相关实验视频
Updated: Jan 10, 2026

09:52
Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
9.9K
在癌症患者中遗传免疫特征和西斯普拉丁诱导的耳毒性:孟德尔的随机化研究
Yang Zheng1, Xin Yang1, Shangjun Hua1
1Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
International journal of clinical pharmacy
|November 20, 2025
概括
像TGF-β PCA这样的遗传免疫特征在儿童和成人中不同地影响着西斯的耳毒性. 这表明,针对个性化癌症治疗策略的免疫遗传特征.
科学领域:
- 药物基因组学 药物基因组学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 西斯普拉丁化疗可以导致听力损失 (耳毒性).
- 免疫系统的变化可能会影响个体对西斯的耳毒性敏感性.
- 在这个过程中,遗传免疫特征的作用尚不清楚.
研究的目的:
- 调查33种遗传免疫特征与西斯胺诱导的耳毒性之间的因果关系.
- 确定特定于年龄的遗传标记,用于预测癌症幸存者的耳毒性风险.
主要方法:
- 门德尔的随机化 (MR) 分析被用来评估遗传关联.
- 全基因组关联研究数据确定了相关的单核酸多态.
- 灵敏度分析和邦费罗尼校正确保了结果的稳定性.
主要成果:
- 转化生长因子-β主要成分分析 (TGF-β PCA) 显示了与年龄相关的对耳毒性的影响.
- 在儿童患者中,TGF-β PCA增加了听力损失的风险,但保护了成年人.
- 在成年人中,对T细胞和PD-1细胞也观察到保护作用.
结论:
- 遗传性免疫特征,包括TGF-β PCA,PD-1和TCM细胞,对西斯的耳毒性具有年龄分层的因果影响.
- 免疫遗传学分析可以帮助预测耳毒性风险.
- 个性化瘤药房实践可能会从这些见解中受益.
相关概念视频
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Mismatch Repair
6.3K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.3K
Mismatch Repair
43.5K
Overview
43.5K
Mutagenicity and Carcinogenicity
1.8K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
Dosage Compensation
7.0K
In animals, gender is determined by the number and type of sex chromosome. For example, human females have two X chromosomes, and males have one X and one Y chromosome, whereas C.elegans with one X chromosome is a male, and the one with two X chromosomes is a hermaphrodite.
In addition to sexual development, the X chromosome has genes involved in autosomal functions such as brain development and the immune system. Therefore, males and females with distinct numbers of X chromosomes will...
In addition to sexual development, the X chromosome has genes involved in autosomal functions such as brain development and the immune system. Therefore, males and females with distinct numbers of X chromosomes will...
7.0K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K

